{
    "title": "Teva Q1 profit tops estimates, revenue up on Actavis deal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4495680/Teva-Q1-profit-tops-estimates-revenue-Actavis-deal.html",
    "date": "2017-05-11",
    "keywords": [
        "teva",
        "business",
        "candidate",
        "revenue",
        "ceo",
        "share",
        "percent",
        "tel",
        "aviv",
        "year",
        "drug",
        "cfo",
        "end",
        "copaxone",
        "forecast",
        "company",
        "market",
        "venezuela",
        "peterburg",
        "fall",
        "profit",
        "acquisition",
        "actavis",
        "executive",
        "vigodman",
        "management",
        "confidence",
        "drugmaker",
        "series",
        "officer",
        "eyal",
        "desheh",
        "june",
        "thursday",
        "michael",
        "mcclellan",
        "july",
        "speciality",
        "division",
        "rival",
        "sanofi",
        "chairman",
        "sol",
        "barer",
        "number",
        "post",
        "board",
        "time",
        "progress",
        "conference",
        "call",
        "requirement",
        "israel",
        "world",
        "thomson",
        "trading",
        "tevas",
        "quarter",
        "absence",
        "competitor",
        "surprising",
        "didnt",
        "beat",
        "analyst",
        "jami",
        "rubin",
        "cost",
        "reduction",
        "instability",
        "future",
        "yitzhak",
        "exchange",
        "venezuelan",
        "bolivar",
        "price",
        "cut",
        "situation",
        "production",
        "health",
        "oncology",
        "pain",
        "europe",
        "debt",
        "dividend",
        "mandatory",
        "reporting",
        "scheer",
        "editing",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}